Chicago-based BIOLIFE4D, a medical tech firm specializing in 3D bioprinting and tissue engineering, announced it has successfully demonstrated its ability to 3D bioprint human cardiac tissue – specifically, a human cardiac patch.
The BIOLIFE4D’s 3D bioprinting process begins with blood sample collection from the patient. Because every cell in a human body has the same number of genes and the same DNA, every cell has the potential to be converted to essentially any other cell. “The speed at which we bioprinted 3D human cardiac patches, within days, is unheard of within the scientific community,” said Dr. Ravi Birla, Chief Science Officer (CSO) at BIOLIFE4D. “These efforts clearly demonstrate our ability to bioprint human tissue and provide a clear and rapid pathway towards bioprinting human hearts.”
Source: Inside 3D Printing News